| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 04/13/1993 | US5202121 Thrombolytic compositions |
| 04/12/1993 | WO1993007118A1 9-substituted bicyclo[3.3.0]octane derivatives, for use as txa2 antagonists |
| 04/12/1993 | CA2097930A1 9-substituted bicyclo[3.3.0]octane derivatives, for use as txa2 antagonists |
| 04/08/1993 | DE4132701A1 Verfahren zur herstellung von staerkeabbauprodukten mit einer engen molekulargewichtsverteilung A process for preparing staerkeabbauprodukten having a narrow molecular weight distribution |
| 04/08/1993 | CA2079705A1 Prostaglandin analogs |
| 04/07/1993 | EP0535925A1 (Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
| 04/07/1993 | EP0535924A1 (Bicyclic-azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
| 04/07/1993 | EP0535337A2 Cell growth inhibiting activities of heparin binding neurite-outgrowth promoting factor |
| 04/07/1993 | EP0535336A2 MK protein as cell growth inhibitor |
| 04/07/1993 | EP0535037A1 Hybrid plasminogen activators |
| 04/06/1993 | US5200397 Administering an oligopeptides anticoagulants or wound healing agents |
| 04/06/1993 | US5199942 Method for improving autologous transplantation |
| 04/06/1993 | US5199375 Folding warning marker |
| 04/06/1993 | CA1315778C Polyhydroxylated and highly fluorinated compounds, their preparation and their use as surfactants |
| 04/06/1993 | CA1315677C Use of epidermal growth factor |
| 04/01/1993 | WO1993006107A1 New ginkgolide derivatives and a process for preparing them |
| 04/01/1993 | WO1993005822A1 Tissue glue prepared by using cryoprecipitate |
| 04/01/1993 | WO1993005791A1 Prevention of hemolysis |
| 04/01/1993 | WO1993005781A1 Novel alpha-mannosidase inhibitors |
| 04/01/1993 | WO1993005773A1 Therapeutic inhibition of platelet aggregation by nucleophile-nitric oxide complexes and derivatives thereof |
| 04/01/1993 | CA2119005A1 Prevention of hemolysis |
| 03/31/1993 | EP0534492A2 Carboxyalkyl substituted inhibitors of enkephalinase and ACE |
| 03/31/1993 | EP0534443A1 3,6-Disubstituted pyridazine derivatives |
| 03/31/1993 | EP0534396A2 2-Substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace |
| 03/31/1993 | EP0534383A2 Process for preparing human coagulation factor VIII protein complex |
| 03/31/1993 | EP0534363A2 Novel 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 03/31/1993 | EP0533930A1 Use of a macrolide compound such as fk 506 for manufacturing a medicament for treating idiopathic thrombocytopenic purpura and basedow's disease |
| 03/31/1993 | EP0533862A1 Recombinant human factor viii derivatives |
| 03/31/1993 | CN1070397A Indolesulphonamide-substituted dihydropyridines, processes for their preparation and their use in medicaments |
| 03/31/1993 | CA2079291A1 Activities of heparin binding neurite-outgrowth promoting factor |
| 03/31/1993 | CA2079290A1 Activities of mk protein |
| 03/30/1993 | CA1315479C Platelet-aggregation inhibitor peptide derivatives |
| 03/27/1993 | CA2078699A1 3,6-disubstituted pyridazine derivatives |
| 03/25/1993 | CA2078721A1 Process for preparing human coagulation factor viii protein complex |
| 03/24/1993 | EP0533130A1 2-Hydroxymethylpyridines, the corresponding pyridine-N-oxides and derivatives thereof, process for their preparation and their use |
| 03/24/1993 | EP0533014A1 Indolesulfonamide substituted dihydropyridines, process for their preparation and drugs containing them |
| 03/24/1993 | EP0532531A1 Phenol and pyridinol derivatives as pharmaceuticals |
| 03/24/1993 | EP0346413B1 Potentiation of erythropoiesis |
| 03/24/1993 | CN1070190A Heterocyclically substituted quinolylmethoxy-phenylacetamides |
| 03/23/1993 | US5196511 Peptides and antibodies that inhibit integrin-ligand binding |
| 03/23/1993 | US5196404 Inhibitors of thrombin |
| 03/23/1993 | CA1314889C Glycerol derivatives, their preparation and their therapeutic use |
| 03/21/1993 | CA2078498A1 Indolesulphonamide-substituted dihydropyridines, processes for their preparation and their use in medicaments |
| 03/20/1993 | CA2078590A1 2-hydroxymethylpyridines, the corresponding pyridine n-oxides and their derivatives, processes for their preparation and their use |
| 03/18/1993 | WO1993005169A1 Hybrid cytokines |
| 03/18/1993 | WO1993005150A1 Collagen-induced platelet aggregation inhibitor |
| 03/18/1993 | WO1993005074A1 Dermatan sulphate possessing a thrombolytic activity, and pharmaceutical forms containing it |
| 03/18/1993 | WO1993005070A1 Peptide inhibitors of inflammation mediated by selectins |
| 03/18/1993 | WO1993005069A1 New isosteric peptides |
| 03/18/1993 | WO1993005067A1 Topical fibrinogen complex |
| 03/18/1993 | WO1993005031A1 (3s,4s)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them |
| 03/18/1993 | CA2118695A1 Peptide inhibitors of inflammation mediated by selectins |
| 03/18/1993 | CA2117174A1 Collagen-induced platelet aggregation inhibitor |
| 03/18/1993 | CA2117058A1 Topical fibrinogen complex |
| 03/18/1993 | CA2116533A1 Hybrid cytokines |
| 03/18/1993 | CA2116527A1 New isosteric peptides |
| 03/18/1993 | CA2116437A1 Dermatan sulphate possessing a thrombolytic activity, and pharmaceutica l forms containing it |
| 03/17/1993 | EP0531883A1 Condensed 5-membered ring heterocycles, process for their preparation and medicaments containing them |
| 03/17/1993 | EP0531598A1 1,4-Dihydropyridines with paf-antagonistic activity |
| 03/17/1993 | EP0531548A1 Carbostyril derivatives as anti-thrombotic agents |
| 03/17/1993 | CN1069971A Novel sulfonamide fibrinogen receptor antagonists |
| 03/17/1993 | CN1020100C Process for benzopyran derivatives |
| 03/17/1993 | CN1020098C Production for thiolactam-N-acetic acid derivatives |
| 03/10/1993 | EP0531078A1 (R)-3-Methoxy-4- 1-methyl-5-(2-methyl-4,4,4-trifluorobutylcarbamoyl)indol-3-ylmethyl -N-(2-methylsulphonyl)benzamide in crystalline form |
| 03/10/1993 | EP0530937A1 Collagen-induced platelet aggregation inhibitor |
| 03/10/1993 | EP0530639A1 Quinolylmethoxy-phenylacetamides substituted by a heterocycle as lipoxygenase inhibitors |
| 03/10/1993 | EP0530505A2 Hydantoin derivatives |
| 03/10/1993 | EP0530444A1 Aryl, amide, imide, and carbamate pyridine antagonists of platelet activating factor |
| 03/10/1993 | CN1069741A Polyoxypropylene/polyoxyethylene copolymers with improved biological activity |
| 03/10/1993 | CN1069736A New isosteric peptides |
| 03/10/1993 | CA2074419A1 1,4-dihydropyridines with paf-antagonistic activity |
| 03/10/1993 | CA2050948A1 5-benzyl substituted-benzimidazo-line-2-thion derivatives and a process for preparing the same |
| 03/09/1993 | US5192746 Cyclic cell adhesion modulation compounds |
| 03/09/1993 | CA1314290C Hydroxamic acids of 7-oxabicycloheptane substituted ethers |
| 03/09/1993 | CA1314232C Amino acid composition for parenteral nutritional support |
| 03/07/1993 | CA2077577A1 Condensed 5-membered heterocyclic compounds, processes for preparing them and pharmaceutical preparations containing these compounds |
| 03/07/1993 | CA2077465A1 Heterocyclically substituted quinolylmethoxy-phenylacetamides |
| 03/06/1993 | CA2076722A1 Pharmaceutical agents |
| 03/04/1993 | WO1993004048A1 New pyrazine derivatives, their preparation and their use |
| 03/04/1993 | WO1993003738A1 Method for treating vascular obstructions caused by abnormal cells |
| 03/04/1993 | CA2115755A1 New pyrazine derivatives, their preparation and their use |
| 03/04/1993 | CA2115361A1 Method for treating vascular obstructions caused by abnormal cells |
| 03/03/1993 | EP0530167A1 New isosteric peptides |
| 03/03/1993 | EP0529715A1 Sulfated glycosaminoglycanoid derivatives |
| 03/03/1993 | EP0529702A1 Dihydropyridine derivatives, their preparation and their use |
| 03/03/1993 | EP0529450A1 Substituted mandelic acid derivatives as 5-lipoxygenase inhibitors |
| 03/03/1993 | EP0529031A1 Improved inhibitors of thrombin |
| 03/03/1993 | EP0528926A1 Soluble peptide analogues containing binding sites |
| 03/03/1993 | EP0528841A1 A method for the preparation of pyridoxylated hemoglobin |
| 03/03/1993 | EP0315698B1 Thieno(triazolo)diazepine compounds and medicinal application of the same |
| 03/02/1993 | US5191092 Antithrombotic iso- and heterocyclic phenylsulphonamides |
| 03/02/1993 | CA1314044C Imidazopyridine derivatives |
| 03/02/1993 | CA1314043C 1,4-diazepines |
| 03/01/1993 | CA2076929A1 Substituted mandelic acid derivatives, processes for their preparation and their use in medicaments |
| 02/24/1993 | EP0528716A1 Human hemoglobin derivatives, process for preparing them, products derived therefrom and use of these derivatives and products |
| 02/24/1993 | EP0528701A1 Process of preparation of a human thrombin concentrate for therapeutic use |
| 02/24/1993 | EP0528369A2 Cyclic imino derivatives, pharmaceutical compositions containing them and process for their preparation |
| 02/24/1993 | EP0528172A1 (2-Alkyl-3-pyridyl)methylpiperazine derivatives as PAF antagonists |
| 02/24/1993 | EP0528135A1 Uses of 9,12,15-octadecatrien-6-ynoic acid |
| 02/23/1993 | US5189211 Thromboxane A2 antagonists |